Practical Insight for U.S. Patent Strategy
Explore articles, comparative analyses, and practical guides addressing U.S. patent prosecution, portfolio development, post-grant proceedings, patent eligibility, and emerging technologies. Our publications are designed to help companies, universities, patent owners, foreign associates, and in-house legal teams understand important developments and make informed strategic decisions.
FDA and Intellectual Property Strategies for Medical Device Technologies
Medical-device innovation often sits at the intersection of patent protection, FDA regulation, software, artificial intelligence, and commercialization strategy. Brandon Theiss is a co-author of both editions of FDA and Intellectual Property Strategies for Medical Device Technologies, a practical resource addressing intellectual-property considerations throughout the development and commercialization of regulated medical technologies.
The second edition expands the discussion to include artificial intelligence, software, and other emerging applications shaping the medical-device industry.

Available Online
Springer Nature AmazonFirst Edition

Available Online
Springer Nature AmazonSecond Edition
Scholarship on Patent Law, Technology, & Innovation
Explore articles published in legal, academic, and professional journals addressing developments in patent law, prosecution strategy, emerging technologies, and the relationship between intellectual property and commercial innovation.
A Fed. Circ. Blueprint For Drafting Medical Device Patents
Law360
Read Article →PTAB Memo Recenters Discretion On US Manufacturing
Law360
Read Article →Including a Description of Technical Advantages During Patent Application Drafting May Help Patent Eligibility
Intellectual Property Law Section Proceedings
Read Article →How Patent Eligibility Declarations Can Stave Off Rejection
Law360
Read Article →ChatGPT Meets the POSITA: How AI Is Reshaping the Foundations of Patent Law
The Legal Intelligencer
Read Article →Open Source, Closed Door: Managing Patent Risk in Open Source (OSS)-Driven Products
The Legal Intelligencer
Read Article →Recent Divergent Blog Posts

Choosing an ISA After the Korean Fee Increase: A practical comparison for US PCT applicants

Make Web ADS the Default for Cleaner Patent Filings

